| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 75,504 | 70,083 | 60,671 | 74,330 | | Cost of Revenue | 18,492 | 19,282 | 20,617 | 20,691 | | | Gross Profit | 57,012 | 50,801 | 40,054 | 53,639 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 29,308 | 27,043 | 29,159 | 27,473 | | Non Recurring |
-
|
-
| 48,953 | 85,284 | | Others | 5,361 | 5,259 | 5,255 | 5,067 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 22,343 | 18,499 | (43,313) | (64,185) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1 | (67) | 1,289 | 67,104 | | Earnings Before Interest And Taxes | 19,226 | 19,179 | (40,874) | 3,185 | | Interest Expense | 9,224 | 9,033 | 10,779 | 13,140 | | Income Before Tax | 10,002 | 10,146 | (51,653) | (9,955) | | Income Tax Expense | (1,508) | 1,777 | 7,071 | (4,208) | | Minority Interest | (3,650) |
-
|
-
| (856) | | | | Net Income From Continuing Ops | 16,025 | 8,369 | (58,724) | (6,603) | | | Non-recurring Events | | Discontinued Operations | (87) | (89) | 158 | 298 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,288 | 8,280 | (58,566) | (6,305) | | Preferred Stock And Other Adjustments | 1,938 | (1,067) | (871) |
-
| | | Net Income Applicable To Common Shares | $14,226 | $7,213 | ($59,437) | ($6,305) |
|
0.26% Nasdaq 
0.38 (10.41%) 
Income Statement
